| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Tvardi Therapeutics, Inc.
13G/A
CARA · 140755208
|
3.4% |
8/5/2025
Event 7/7/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.